Umbilical Cord-Derived Mesenchymal Stem Cells are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications

Mesenchymal stem cells (MSCs) have become a promising tool in cellular therapy for restoring immune system haemostasis; however, the success of clinical trials has been impaired by the lack of standardized manufacturing processes. This study aims to determine the suitability of source tissues and cu...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Lenka Tesarova, Klara Jaresova, Pavel Simara, Irena Koutna
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI AG 2020-07-01
סדרה:International Journal of Molecular Sciences
נושאים:
mesenchymal stem cells
umbilical cord
advanced therapy medicinal product
immunosuppression
גישה מקוונת:https://www.mdpi.com/1422-0067/21/15/5366
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים